Skip to content
HowShorted

TG THERAPEUTICS, INC. short interest in 2019

In 2019, TG THERAPEUTICS, INC.'s disclosed short interest ran from 14.55% of shares outstanding on 15 Jan 2019 to 12.92% on 31 Dec 2019, a change of -1.63 percentage points. The year's high was 21.28% on 29 Mar 2019 and its low 12.81% on 13 Dec 2019, averaging 15.81% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.77 days on 30 Aug 2019. Full history: TG THERAPEUTICS, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for TG THERAPEUTICS, INC. in 2019

2019 in figures

Start of year
14.55% (15 Jan 2019)
End of year
12.92% (31 Dec 2019)
Change
-1.63 pp
High
21.28% (29 Mar 2019)
Low
12.81% (13 Dec 2019)
Average
15.81%
Highest days to cover
14.77 (30 Aug 2019)
SEC filings marked
7

Every report in 2019

TG THERAPEUTICS, INC. short interest in 2019
SettlementShort interestDays to coverFilings since previous
15 Jan 201914.55%9.57
31 Jan 201915.92%8.74
15 Feb 201917.20%9.34
28 Feb 201915.91%5.04
15 Mar 201920.86%4.6010-K filed
29 Mar 201921.28%7.39
15 Apr 201920.39%7.08
30 Apr 201918.41%9.54
15 May 201916.80%10.3110-Q filed, results (8-K)
31 May 201914.92%8.72
14 Jun 201915.88%11.26
28 Jun 201915.88%6.92
15 Jul 201916.40%9.92
31 Jul 201914.69%14.69
15 Aug 201914.42%12.3510-Q filed, results (8-K)
30 Aug 201915.37%14.77
13 Sep 201914.71%12.51
30 Sep 201913.86%9.90
15 Oct 201913.82%13.83
31 Oct 201914.88%11.07
15 Nov 201914.00%9.4110-Q filed, results (8-K)
29 Nov 201913.63%6.86
13 Dec 201912.81%4.26
31 Dec 201912.92%7.88

See also: TG THERAPEUTICS, INC.'s full history · most shorted US stocks of 2019 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.